author-photo

A. Sangiovanni

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
University of Milan

197

Papers

6138

Citations

Citation Trend

Filter By

Papers (137) Sort By

Journal Conference Others

FRI-376-Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance

2019 Annals of Hepatology
Show All
- Source
- Cite
- Save
Citations (2)
Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)
AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)
Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma

2019 Hepatology
Show All
- Source
- Cite
- Save
Citations (29)
Factors Associated with Increased Risk of de Novo or Recurrent Hepatocellular Carcinoma in Patients with Cirrhosis Treated with Direct-Acting Antivirals for HCV Infection

2019 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (46)
The development of hepatolocellular carcinoma is not predicted by genetic variants in caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 10 years

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)
Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival

2018 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (2)
Changes of AFP and PIVKA-II levels during DAA treatment and their predictive value for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment

2018 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)
Incidence and predictors of de novo hepatocellular carcinoma in HCV cirrhotic patients treated with direct-acting antivirals: A single-center prospective 3-year study

2018 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (2)